<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Neurosci.</journal-id>
<journal-title>Frontiers in Cellular Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-5102</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fncel.2023.1269180</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular Neuroscience</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Environmental effect on neuroinflammation and neurodegeneration, volume II</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Sarkar</surname> <given-names>Souvarish</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/828744/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Rangaraju</surname> <given-names>Srikant</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/465302/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Espinosa-Garcia</surname> <given-names>Claudia</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/515062/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Langley</surname> <given-names>Monica Renee</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/851607/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Environmental Medicine, University of Rochester Medical Center</institution>, <addr-line>Rochester, NY</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Neurology, Emory University</institution>, <addr-line>Atlanta, GA</addr-line>, <country>United States</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic</institution>, <addr-line>Rochester, MN</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited and reviewed by: Dirk M. Hermann, University of Duisburg-Essen, Germany</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Monica Renee Langley <email>Langley.monica&#x00040;mayo.edu</email></corresp>
<corresp id="c002">Souvarish Sarkar <email>souvarish_sarkar&#x00040;urmc.rochester.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>08</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>17</volume>
<elocation-id>1269180</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>07</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>07</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2023 Sarkar, Rangaraju, Espinosa-Garcia and Langley.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Sarkar, Rangaraju, Espinosa-Garcia and Langley</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license> </permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/research-topics/43873/environmental-effect-on-neuroinflammation-and-neurodegeneration-volume-ii" ext-link-type="uri">Editorial on the Research Topic <article-title>Environmental effect on neuroinflammation and neurodegeneration, volume II</article-title></related-article>
<kwd-group>
<kwd>neuroinflammation</kwd>
<kwd>neurodegeneration</kwd>
<kwd>microglia</kwd>
<kwd>pesticides</kwd>
<kwd>epigenetics</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="2"/>
<word-count count="1246"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Cellular Neuropathology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Emerging epidemiological data in the last decade have indicated that environmental factors like pesticides, and metals, among others, play a critical role in driving neurodegenerative disorders like Alzheimer&#x00027;s disease (AD), Parkinson&#x00027;s disease (PD), and others. Recent research in cell culture and animal models has further shown that exposure to these neurotoxicants leads to neuroinflammation and neurodegeneration through various mechanisms. With the field of environmental toxicology gaining prominence, this set of articles in the Research Topic titled &#x0201C;<italic>Environmental effects on Neuroinflammation and neurodegeneration volume II</italic>&#x0201D; concentrated on the potential role of epigenetics in regulating neuroinflammation as well as the mechanism of various environmental factors contributing to neurodegeneration.</p></sec>
<sec id="s2">
<title>Epigenetics and neuroinflammation and neurodegneration</title>
<p>Recent studies have shown that immune cells can memorize exposure to a chemical or micro-organism and then mount a more robust immune response when exposed to similar xenobiotics or chemicals. This concept is known as trained immunity. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1052925">Huang et al.</ext-link> demonstrated both <italic>in vitro and in vivo</italic> that microglial cells, the brain&#x00027;s resident immune cells, exhibit trained immunity in response to a neurotoxic metal, manganese, that has been shown to increase the risk of PD. Furthermore, this study showed that epigenetic markers modulate this trained immune response in microglia cells in vitro and in mice in response to LPS priming and subsequent Mn exposure. H3K27ac and H3K4me3, along with H3K4me1, were all upregulated, leading to microglial cells mounting an enhanced response.</p>
<p>IFN-&#x003B2; was one of the first disease-modifying therapies approved for Multiple Sclerosis. In a clinical study, by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1162796">Xavier et al.</ext-link> demonstrated that IFN-&#x003B2; treatment reduced the whole blood DNA methylation profiles of various genes that are targeted by interferons. This study suggests that epigenetic markers play a key role on MS etiology and drive neuroinflammation and neurodegeneration.</p></sec>
<sec id="s3">
<title>Neurodegeneration and pesticide exposure</title>
<p><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fncel.2023.1195843">Meyer et al.</ext-link> presented novel work on the NADPH oxidase inhibitor, mitoapocynin, as a feasible countermeasure in an animal model of organophosphate (OP) toxicity. Their study specifically uses a rat model of diisopropylflurorophospate (DFP) exposure to demonstrate promising improvements in several inflammatory and oxidative stress markers in the serum of mitoapocynin-treated mice 1-week post-challenge; although NOX2 protein upregulation in response to DFP as well as reactive gliosis indicators was not attenuated in the brain tissue. Overall, the study highlights the need for follow-up dose optimization studies for promising compounds to effectively dampen environmental responses in neuroinflammatory and neurodegenerative effects in the central nervous system. Although the conceivable utility of mitoapocynin has now been shown across several rodent models of neurodegenerative and neuroinflammatory conditions, careful and sufficient dosing or perhaps alternative administration routes will need to be considered to fully overcome reactive gliosis and oxidative damage in the CNS. This is especially true for OPs, for which there are no effective medical countermeasures to mitigate chronic health effects from resulting exposures.</p></sec>
<sec id="s4">
<title>Pollution and amyotrophic lateral sclerosis</title>
<p><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fneur.2023.1108383">Saucier et al.</ext-link> published a systematic review, finding almost 50 epidemiological studies evaluating alleged connections among urbanization, air pollution, and water pollution with the development of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig&#x00027;s disease. Importantly, this study cast a wider net to look at several exposure routes within the same systematic review as well as branched out from previous works that focused on rural settings or single contaminants of concern. Moreover, very few studies have carefully assessed the quality of individual articles included in reviews discussing environmental factors possibly linked to ALS. Although urbanization was the most well-studied, there was no clear association with ALS. In terms of air pollution as a risk factor, diesel exhaust exposure and its primary product of combustion, nitrogen dioxide, were linked to an increased risk of ALS. Water pollution also had two potential risk factors of ALS: heavy metal contamination, selenium, as well as proximity of residence to lakes prone to cyanobacterial blooms.</p>
<p>This Research Topic highlights how our epigenome may play a critical role in driving neuroinflammation and in the pathogenesis of neurological diseases. Innate, as well as adaptive immunity, may also play important roles in driving neuroinflammation through trained immunity. With the dawn on exposomics as well as our increase in knowledge about the effects of per- and polyfluorinated alkyl substances (PFAS), also known as &#x0201C;forever chemicals,&#x0201D; we anticipate that the interactions between environmental exposures and mechanisms of neuroinflammatory and neurodegenerative diseases will be an active area of research for years to come.</p></sec>
<sec sec-type="author-contributions" id="s5">
<title>Author contributions</title>
<p>SS: Writing&#x02014;original draft, Writing&#x02014;review and editing. SR: Writing&#x02014;review and editing. CE-G: Writing&#x02014;review and editing. ML: Writing&#x02014;original draft, Writing&#x02014;review and editing.</p></sec>
</body>
<back>
<sec sec-type="funding-information" id="s6">
<title>Funding</title>
<p>This work was supported by NIH grant ES033723 to SS and National Multiple Sclerosis Society Grant FG-1908-348 19 to ML.</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s7">
<title>Publisher&#x00027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>
